Holdings of Remedium Capital Partners, LLC
5 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 100 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 5 | 274.5M $ | 100.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Oruka Therapeutics Inc | 1,565,661 | 76.8M $ | |
| 2 | Spyre Therapeutics Inc | 1,456,231 | 73.5M $ | |
| 3 | DAMORA THERAPEUTICS INC | 2,045,473 | 53M $ | |
| 4 | Apogee Therapeutics Inc | 583,591 | 49.1M $ | |
| 5 | JADE BIOSCIENCES INC | 1,577,750 | 22.2M $ |